SpinePoint has a dynamic cage that is used in patients undergoing fusion surgery with patents granted in the US, China, Korea and Europe and is already in use by 3rd parties in regions of the world where the intellectual property was not secured. The success by 3rd parties in the unsecured global markets demonstrates that SpinePoint is poised to be successful in the multibillion dollar fusion market globally where the IP has been secured.